Showing results (21-30 of 253) with videos related to
Sort By:
Pageof 26
Blood|October 18, 2017
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapyJoshua A Hill, Daniel Li, Kevin A Hay, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 7, 2021
CAR-T Cell Therapy for Acute Myeloid Leukemia: Preclinical Rationale, Current Clinical Progress, and Barriers to SuccessSalvatore Fiorenza, Cameron J TurtleImmunometabolism|February 8, 2021
Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell TransplantationSalvatore Fiorenza, Cameron J TurtleCurrent Research in Translational Medicine|April 8, 2018
Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapyJordan Gauthier, Cameron J TurtleBlood|February 25, 2016
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapyRebecca Gardner, David Wu, Sindhu Cherian, et al.Expert Opinion on Biological Therapy|February 19, 2020
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapyCassie K Chou, Cameron J TurtleAmerican Journal of Hematology|February 21, 2019
Toxicities of CD19 CAR-T cell immunotherapyAlexandre V Hirayama, Cameron J TurtleBone Marrow Transplantation|August 22, 2019
Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapyCassie K Chou, Cameron J TurtleFrontiers in Immunology|July 9, 2026
The impact of the large B-cell lymphoma tumor microenvironment on efficacy of CD19-directed CAR-T immunotherapyHelen P Cashman, Cameron J TurtleBlood Cancer Discovery|October 18, 2021
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple MyelomaSylvain Simon, Stanley R RiddellPageof 26